about
MicroRNA-210: a unique and pleiotropic hypoxamirMicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2Genetic Misdiagnoses and the Potential for Health DisparitiesS-nitrosothiols and the S-nitrosoproteome of the cardiovascular systemPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Regulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPx-3) in mammalian cellsPredictors of improved left ventricular systolic function in an urban cardiomyopathy programL-arginine and atherothrombosisCoronary calcium screening and the American Heart Association news embargoRedox regulation of mitochondrial functionThe critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelSystems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General CaseImpaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunctionIncreased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenaseInflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant miceHeterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structureGenetics and beyond--the transcriptome of human monocytes and disease susceptibilityPrecision medicine in cardiology.Future translational applications from the contemporary genomics era: a scientific statement from the American Heart AssociationThe Future of Medical Journal Publishing: The Journal Editor's Perspective: Looking Back, Looking Forward.Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide.Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis.Clinical problem-solving. A patient with syncope.Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels.Clinical problem-solving. Breathless.Quo vadis: whither homocysteine research?Oxidative risk for atherothrombotic cardiovascular disease.Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria.S-nitrosoprotein formation and localization in endothelial cells.Network analysis of the genomic basis of the placebo effect.Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series).DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections.Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis.High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis.Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression.Analyzing networks of phenotypes in complex diseases: methodology and applications in COPDSerum selenium and prognosis in cardiovascular disease: results from the AtheroGene studyInhibition of cellular methyltransferases promotes endothelial cell activation by suppressing glutathione peroxidase 1 protein expression.Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease.Systems analysis of oxidant stress in the vasculature
P50
Q24601095-39ED5346-8C77-4331-B6B6-51826256613AQ24655427-B79F4292-2E54-48CE-9F57-A56D68D0FFA4Q26316693-8E560A6E-D132-4877-8136-F0450FE327CEQ26852676-6BB58094-7EBF-4A69-AB57-1238A5F91574Q27687091-7497F04E-9F8F-4084-9262-FFDB6710195EQ28116864-1CB40214-E31B-4D46-ABA2-6AAC9663C3CAQ28211771-B0F3522D-2F36-42F9-BA9A-AAF7AB122F48Q28286126-FB15B3CE-9512-4D6C-977B-0BFCC3556DAEQ28297016-E1DF8336-15AC-467C-9014-479293112919Q28383361-AFFD9AD1-E04D-498A-827B-2E01F4363C93Q28512770-63CD4549-475B-4B00-95D1-D1E557DAA22FQ28550867-6F4D7482-8366-44BE-B26B-6CB2302181B5Q28586372-2C51D354-77A2-40E3-A9F9-F2974EC636E6Q28587379-F8C853E4-3162-49E4-9554-EC4C8812D815Q28590362-F22DED8C-C3C9-4D2E-AB60-4E523B0E47A0Q28592048-7D14AD38-0F30-4D40-8C95-06432ED09291Q28752094-DACB5434-2741-4DEC-AA47-FD4FA0066766Q30249224-46A054BB-1DAA-4543-88C8-4E78BBC08313Q30359686-B10AD0FB-23FF-4072-B84D-D7018A485336Q30489290-7C909973-F5B0-458A-8CEE-7D0275AE85D0Q30890753-17C5A144-06FF-4E6B-B224-0A3016178277Q30939997-A0A15705-A7BD-4589-9984-03D8D259D4CAQ33163234-AF6EB956-417C-4162-92B0-372EB12E811CQ33193342-96513A23-E178-4ED0-9E9C-F03C489B5314Q33399031-2A0AB370-C6FE-4E6D-9510-704986B67B3FQ33457245-C60C7A29-31D0-4462-9B3C-20ADAEEE2A09Q33554184-2A40DEB0-FDA2-4C5B-AF5D-24621AE0375BQ33613186-78054598-3922-49EB-B482-842E6B7DCE55Q33715470-7993B029-3B54-4EB5-9DA7-7A58CDF54B52Q33752381-569D965D-453C-4AE1-9F61-4A2128F3A256Q33806018-6E57708F-D4D9-486A-8E25-B7FE81BBE1FBQ33860701-160EF676-4142-483B-AAAE-75683C03ED1BQ33877343-C6954976-77A2-4BAD-BCF6-51B1A2D3B035Q33890987-0DCA6490-D549-4C52-A6A0-2E5B870AFD90Q33919459-4A20F476-1A34-459E-B481-11CA98D6CFB8Q33929376-90204BFF-1C27-4B13-BE20-3A29F7C56F65Q34066398-A78D0F88-E026-4957-8266-10791FFF7D47Q34075905-A4229A17-F6A9-44B0-91A5-0983DDF41D1BQ34107505-411E18B8-A6F9-498C-A8F6-AB60DEB2EBD4Q34306963-8D983D69-B67B-48EF-B75A-84E9202DC09B
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Joseph Loscalzo
@ast
Joseph Loscalzo
@en
Joseph Loscalzo
@es
Joseph Loscalzo
@nl
type
label
Joseph Loscalzo
@ast
Joseph Loscalzo
@en
Joseph Loscalzo
@es
Joseph Loscalzo
@nl
prefLabel
Joseph Loscalzo
@ast
Joseph Loscalzo
@en
Joseph Loscalzo
@es
Joseph Loscalzo
@nl
P1006
P214
P950
P1006
P106
P21
P214
P31
P496
0000-0002-1153-8047
P569
1951-01-01T00:00:00Z
P691
nlk20050166688
P735
P7859
lccn-n87858308